VDR and diabetes mellitus: Suppression of Pin1, through gene silencing, Juglone treatment, Vitamin D receptor (VDR) agonists, or bromocriptine-QR, alleviates chronic oxidative stress and vascular dysfunction induced by diabetes (Paneni et al., 2015; Costantino et al., 2016; Zhang et al., 2018; Cincotta et al., 2022).